Volume 9, Issue 4 (7-2011)                   IJRM 2011, 9(4): 295-300 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Osmanova S, Turan V, Zeybek B, Cosan Terek M, Lutfiye K. The effects of raloxifene treatment on oxidative status in brain tissues and learning process of ovariectomized rats. IJRM 2011; 9 (4) :295-300
URL: http://ijrm.ir/article-1-238-en.html
The effects of raloxifene treatment on oxidative status in brain tissues and learning process of ovariectomized rats
Süreyya Osmanova * , Volkan Turan , Burak Zeybek , Mustafa Cosan Terek , Kanıt Lutfiye
Abstract:   (2508 Views)
Background: The effects of estrogene on central nervous system are still controversial.
Objective: We aimed to investigate the effects of raloxifene on the antioxidant enzyme [superoxide dismutase (SOD) and catalase (CAT)] activities and malondialdehyde (MDA) levels in brain homogenates of ovariectomized female rats and its effect on cognitive process of learning.
Materials and Methods: Female Sprague Dawley rats (n=24) were divided into three groups. Three weeks after ovariectomy; nonovariectomized group (control group) (n=8) was given physiological saline (SP) as placebo. First ovariectomized group (n=8) received raloxifene 1mg/kg dissolved in a 1% solution of carboxymethylcellulose (CMC) subcutaneusly (sc) and second group of ovariectomized rats were given 1 % CMC 1mg/kg (sc) every day for 14 days. Learning behaviors of rats were evaluated in active avoidence cage with using sound and electrical stimulation. The levels of oxidative stress (MDA) and antioxidant enzymes (SOD, CAT) in different regions of the brain homogenates were compared between three groups of decapitated rats.
Results: Raloxifene had a significant attenuating effect on the levels of MDA in brain tissues suggesting raloxifene’s effect against lipid peroxidation at the end of training days. With the comparison of brain regions, cortex showed the highest average activity of SOD and CAT and cerebellum had the lowest average levels for both. Its effects on learning and cognitive process with active avoidence task were considered insignificant.
Conclusion: Raloxifene treatment may have preventive effects for the brain against oxidative stress and lipid peroxidation in rats.
Keywords: Oxidative stress, Raloxifene, Active avoidence task, Cognitive process.
Full-Text [PDF 434 kb]   (470 Downloads) |   |   Full-Text (HTML)  (280 Views)  
Type of Study: Original Article |
References
1. Huster WJ, Shah A, Cohen F. Effect of raloxifene on the endometrium in healthy postmenopausal women. 8th Annual Meeting of the North American Menopause Society; Massachusetss; 1997.
2. Yaffe K, Kruger K, Sarkar S, Grady D, Barrett- Connor E, Cox DA, et al. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 2001; 3441: 1207-1213. [DOI:10.1056/NEJM200104193441604]
3. Oge A, Sezer ED, Ozgonul M, Bayraktar F, Sozmen EY. The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats. Neuroscience Letters 2003; 338: 217-220. [DOI:10.1016/S0304-3940(02)01416-7]
4. Chan PH. Role of oxidants in ischemic brain damage. Stroke 1996; 27: 1121-1128. [DOI:10.1161/01.STR.27.6.1124]
5. Rumley AG, Paterson JR. Analytical aspects of antioxidants and free radical activity in clinical biochemistry. Ann Clin Biochem 1998; 35: 181-200. [DOI:10.1177/000456329803500202]
6. Kirsch I, Lynn SJ, Vigorito M, Miller RR. The role of cognition in classical and operant conditioning. J Clin Psychol 2004; 60: 369-392. [DOI:10.1002/jclp.10251]
7. Haskell SG, Richardson ED, Horwitz RI. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature J Clin Epidemiol 1997; 50: 1249-1264. [DOI:10.1016/S0895-4356(97)00169-8]
8. Barrett- Connor E, Kritz- Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269: 2637-2641. [DOI:10.1001/jama.1993.03500200051032]
9. Phillips SM, Sherwin BB. Effects on estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17: 485-495. [DOI:10.1016/0306-4530(92)90007-T]
10. Kimura D. Estrogen replacement therapy may protect against intellectual decline in potmenopausal women. Horm Behav 1995; 29: 312-321. [DOI:10.1006/hbeh.1995.1022]
11. Prange- Kiel J, Wehrenberg U. Para/ autocrine regulation of estrogen receptors in hippocampal neurons. Hippocampus 2003; 13: 226-234. [DOI:10.1002/hipo.10075]
12. A.M. Etgen, G.B. Karkanias, Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychonbeuroendocrinology 1994; 19: 603-610. [DOI:10.1016/0306-4530(94)90044-2]
13. Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 1994; 83: 979-983. [DOI:10.1097/00006250-199406000-00017]
14. Strickler R, Stowall DW, Merritt D, Shen W, Wong M, Silfen SL. Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: Aplacbo- controlled randomized trial. Obstet Gynecol 2000; 96: 359-365. [DOI:10.1097/00006250-200009000-00008]
15. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, et al . Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxideproduction. Circulation 2002; 105: 2083-2091. [DOI:10.1161/01.CIR.0000014618.91633.67]
16. Baker VL, Draper MW, Paul S, Allerheiligen S, Glant M, Shifren J, et al. Reproductive endocrine and endometrial effects of raloxifene HCl, a selective estrogen receptor modulator, in women with regular menstruel cycles. J Clin Endocrinol Metab 1998; 83: 6-13.
17. Martino S, Disch D, Dowsett SA, Keech CA, Mershon JL Safety assessment of raloxifene over eight years in a clinical trial setting. Curr Med Res Opin 2005; 21:1441-1452. [DOI:10.1185/030079905X61839]
18. Grady D, Ettinger B, Moscarelli E, Plouffe L Jr, Sarkar S, Ciaccia AC, et al. Multiple Outcomes of Raloxifene Evaluation Investigators Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation Obstet Gynecol 2004; 104: 837-844. [DOI:10.1097/01.AOG.0000137349.79204.b8]
19. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr Rev 2010; 31: 224-253. [DOI:10.1210/er.2009-0036]
20. Henderson VW, Brinton RD. Menopause andmitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res 2010; 182: 77-96. [DOI:10.1016/S0079-6123(10)82003-5]
21. Topçuoglu A, Uzun H, Balci H, Karakus M, Coban I, Altug T, et al. Effects of estrogens on oxidative protein damage in plasma and tissues in ovariectomised rats. Clin Invest Med 2009; 32: 133-143. [DOI:10.25011/cim.v32i2.6031]
22. Ghidoni R, Boccardi M, Benussi L, Testa C, Villa A, Pievani M, et al. Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. Maturitas 2006; 54: 222-228. [DOI:10.1016/j.maturitas.2005.11.002]
23. Ozgonul M; Öge A; Sezer E; Bayraktar F; Sözmen E. The effects of estrogen and raloxifene treatment on antioxidant enzymes in brain and liver of ovarectomized female rats. Endocrine Research 2003; 29: 183-189. [DOI:10.1081/ERC-120022299]
24. Konyalioglu S, Durmaz G, Yalcin A. The potential antioxidant effect of raloxifene treatment:a study on heart, liver and brain cortex of ovariectomized female rats. Cell Biochem Funct 2007; 25: 259-266. [DOI:10.1002/cbf.1328]
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb